Illumina Cash Flow Statement
NASDAQ: ILMNHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Illumina free cash flow
In fiscal 2025, Illumina generated $1.08 billion of operating cash flow and spent $148.0 million on capital expenditures. That left free cash flow of $931.0 million, a free-cash-flow margin of 21.4% of revenue. Free cash flow was up 31.3% from the prior year's $709.0 million.
Illumina returned $742.0 million to shareholders through share repurchases, equal to 80% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Illumina cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-28 | FY 20242024-12-29 | FY 20232023-12-31 | FY 20222023-01-01 | FY 20212022-01-02 | FY 20202021-01-03 | FY 20192019-12-29 | FY 20182018-12-30 | FY 20172017-12-31 | FY 20162017-01-01 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 850.00M | -1.22B | -1.16B | -4.40B | 762.00M | 656.00M | 990.00M | 782.00M | 678.00M | 428.00M |
| Net Income growth (YoY) | — | — | — | -677.95% | +16.16% | -33.74% | +26.60% | +15.34% | +58.41% | -6.55% |
| Depreciation & Amortization | 270.00M | 354.00M | 432.00M | 394.00M | 251.00M | 187.00M | 188.00M | 179.00M | 156.00M | 141.00M |
| Stock-Based Compensation | 275.00M | 370.00M | 380.00M | 366.00M | 754.00M | 194.00M | 194.00M | 193.00M | 164.00M | 129.00M |
| Change in Working Capital | -131.00M | -464.00M | -78.00M | 212.00M | -125.00M | 90.00M | -126.00M | -5.00M | 40.00M | -54.00M |
| Operating Cash Flow | 1.08B | 837.00M | 478.00M | 392.00M | 545.00M | 1.08B | 1.05B | 1.14B | 875.00M | 779.00M |
| Capital Expenditures | -148.00M | -128.00M | -195.00M | -286.00M | -208.00M | -189.00M | -209.00M | -296.00M | -310.00M | -260.00M |
| Investing Cash Flow | -55.00M | -178.00M | -231.00M | -591.00M | -1.07B | -554.00M | 745.00M | -1.81B | -214.00M | -515.00M |
| Share Repurchases | -742.00M | -116.00M | 0 | 0 | 0 | -736.00M | -324.00M | -201.00M | -251.00M | -249.00M |
| Debt Issued | 495.00M | 1.24B | 0 | 991.00M | 988.00M | 0 | 0 | 735.00M | 5.00M | 5.00M |
| Financing Cash Flow | -744.00M | -570.00M | -1.21B | 1.00B | -51.00M | -766.00M | -897.00M | 594.00M | -176.00M | -296.00M |
| Net Change in Cash | 291.00M | 79.00M | -963.00M | 779.00M | -578.00M | -232.00M | 898.00M | -81.00M | 490.00M | -34.00M |
| Free Cash Flow | 931.00M | 709.00M | 283.00M | 106.00M | 337.00M | 891.00M | 842.00M | 846.00M | 565.00M | 519.00M |
This table shows 10 annual periods of Illumina's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ILMN's reporting calendar. What is a cash flow statement?